tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Apogee Therapeutics 6.95M share Spot Secondary priced at $41.00

Jefferies, BofA, Guggenheim, TD Cowen and BTIG acted as joint book running managers for the offering.

Meet Your ETF AI Analyst

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1